Effects of steroidal and non steroidal drugs on the neovascularization response induced by tumoral TA3 supernatant on CAM from chick embryo

Biological Research

Volumn 36, Issue 2, 2003, Pages 233-240

  Zúñiga, Jorge ^a   Fuenzalida, Marcela ^a   Guerrero, Aníbal ^a   Illanes, Julio ^c   Dabancens, Alfredo ^b   Díaz, Eugenia ^a   Lemus, David ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c NONE

Author keywords

Angiogenesis; Antiangiogenesis; Betamethasone; Ketoprofen; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BETAMETHASONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; STEROID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CHICKEN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LOCALIZATION; FIBROBLAST; INFLAMMATORY DISEASE; ISCHEMIA; MOLECULAR MECHANICS; NONHUMAN; PROTEIN SYNTHESIS; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALIA; GALLUS GALLUS;

EID: 0141494369     PISSN: 07169760     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-97602003000200013     Document Type: Article

References (39)

1. ANGIOLILLO A, SGADARI C, TAUB D, LIAO F, FARBER J, MIAHESHWARI S (1995) Human interferon-inducible protein (IP-10), a member of the c-x-c chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Comm 210: 51-57
2. BARNES P, ADCOCK I (1993) Anti-inflammatory actions of steroids: molecular and mechanisms. Trends Pharmacol Sci 14: 436-41
3. BOUMPAS D, CHROUSOS G, WILDER R, CUPPS T, BALOW J (1993) Glucorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119: 1198-1208
4. BOUMPAS D (1996) A novel action of glucocorticoids NF-κβ inhibition. Br J Rheumatol 35: 709-710
5. BUTTGEREIT F, BRINK I, THIELE B, HIEPE F, BURMESTER GR, HALL E (1995) Effects of methylprednisolone and 21-aminosteroids on mitogen-induced IL-6 and TNF-a production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 275: 850-853
6. BUTTGEREIT F, WEHLING M, BURMESTER GR (1998) A new hypotesis of modular glucocorticoid actions. Arthritis & Rheumatism 41: 761-767
7. CAO Y, CHEN C, WEATHERBEE J, TSANG M, FOLKMAN J (1995) Gro-beta, a c-x-c chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 182: 2069-2077
8. CLAPP C, MARTIAL J, GUZMÁN R, RENTIER-DETRUE F, WEINER R (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133: 1292-1299
9. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis 39: 581-591
10. DANIEL T, LIU H, MORROW J, CREWS B, MARNETT L (1999) Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574-4577
11. FESSLER B, PALIOGIANI F, HAMA N, BALOW J, BOUMPAS D (1996) Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T cells: evidence for postranscriptonal regulation. Transplantation 62: 1113-1118
12. FOLKMAN J (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst: 82: 4-6
13. FOLKMAN J (2000) Cancer Medicine IN: HOLLAND JF (ed), Ontario, Canada: Decker. pp: 132-152
14. FRANK K, REIHER F, VOLPERT O, JIMÉNEZ B, CRAWFORD S, DINNEY C, HENKIN J, HAVIV F, BOUCK N, CAMPBELL S (2002) Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Inc J Cancer 98:682-689
15. FUKUMURA D, XAVIER R, SUGIURA T, CHEN Y, PARK EC, LU N (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725
16. GAVRIELI Y, SHERMAN Y, BEN-SASSON S (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
17. GATELY S, TWARDOWSKI P, STACK MS, PATRICK M, BOGGIO L, CUNDIFF DL (1996) Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis, angiostatin. Cancer Res 56: 4887-4990
18. GOOD DJ, POLVERINI PJ, RASTINEJAD F, LE BEAU MM, LEMONS RS, FRAZIER WA (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from fragment of thrombospondin. Proc Nat Acad Sci 87: 6624-6628
19. GOULDING N, GUYRE P (1993) Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 5: 108-113
20. GRUPTA S, HASSEL T, SINGH J (1995) A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci 92: 7799-7803
21. HAMBURGER V, HAMILTON H (1951) A series of normal stages in the development of the chick embryo. J Morphol 88: 49-92
22. HOPER M, VOELKEL NF, BATES TO, ALLARD JD, HORAN M, SHEPHERD D (1997) Prostaglandins induce vascular endothelial growth factor in human monocytic cell line and rat lungs via AMP. Am J Respir Cell Mol Biol 17: 748-756
23. ILLANES J, FUENZALIDA M, ROMERO S, GONZÁLEZ P, LEMUS D (1999) Ethanol effect on the chick embryo ossification: a macroscopic and microscopic study. Biol Res 32: 77-84
24. KANDEL J, BOSSY-WETZEL E, KLAGSBUM M, FOLKMAN J, HANAHAN D (1991) Neovascularization is associated with a switch to the export of bFGF in the multi-step development of fibrosarcoma. Cell 66: 1095-1104
25. LEMUS D, DABANCENS A, ILLANES J, FUENZALIDA M, GUERRERO A, GONZÁLEZ P (2001) Anti-angiogenic effect of betamethasone on the chick CAM stimulate by TA3 tumor supernatant. Biol Res 34: 227-236
26. MALONNE H, LANGER I, KISS R, ATASSI G (1999) Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clin Exp Metastasis 17: 1-14
27. OREILLY MS, BOEHM T, SHING Y, FUKAI N, VASIOS G, LANE WS (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285
28. PARTON M, DOWSETT M, SMITH I (2001) Studies of apoptosis in breast cancer. BMJ 322: 1528-1531
29. PILCH H, SCHAFFER U, SCHLENGER K, HAWIGHORST H, TANNER B, BAHLMANN F (2000) L'angiogenese dans le cancer du col uterin. Gynecol Obstet Fertil 28: 29-37
30. RADLER-POHL S, GEBEL C, SACHSENMAEIR H, KÖNIG M, KRÄMER T, OEHLER M (1993) The activation and activity control of AP-1. Annals New York Acad Sciences 684: 127-148
31. REED J (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-2953
32. RISTIMÄKI A, NARKO K, HLA T (1996) Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318:325-331
33. STRIETER R, KUNKEL S, AREMBERG D, BURDICK M AND POLVERINI P (1995) Human interferon-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Comm 210: 51-57
34. TOI M, BANDO H, OGAWA T, MUTA M, HORNIG C, WEICH H (2001) Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer, Vol 98: 14-18
35. TAMM I, SCHRIEVER F, DORKEN B (2001) Apoptosis: implications of basic research for clinical oncology. Lancet Oncol 2: 33-42
36. VOEST E, KENYON B, OREILLY M, TRUITT G, DAMATO R, FOLKMAN J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Ins 87: 581-586
37. WILLIAMS C, TSUJII M, REESE J, DEY S, DUBOIS R (2000) Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105: 1589-1594
38. YAMADA M, KAWAI M, KAWAI Y, MASHIMA Y (1999) The effect of selective cyclooxygenase-2-inhibitor on corneal angiogenesis in the rat. Curr Eye Res 19: 300-304
39. ZIPPER J, DABANCENS A, GUERRERO A, TRUJILLO V (1995) Quinacrine revised. Human Reprod Update 1: 324-342